Form 4 for LH Labcorp
Accepted 2023-04-03 00:00:00 ET · period of report 2023-03-30 · accession 0001127602-23-011746 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-03 | 2023-03-31 | LH | Schroeder Mark S | EVP, Pres-Diagnostics Lab | S - Sale | $225.81 | -3,897 | 6,687 | -37% | -$880.0K | |
| 2023-04-03 | 2023-03-30 | LH | Schroeder Mark S | EVP, Pres-Diagnostics Lab | A - Grant | $0.00 | +6,763 | 13.5K | +101% | $0 | |
| 2023-04-03 | 2023-03-30 | LH | Schroeder Mark S | EVP, Pres-Diagnostics Lab | F - Tax | $224.70 | -2,866 | 10.6K | -21% | -$644.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | S | D | 3,897 | $225.81 | 6,687.40 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-30 | A | A | 6,763 | $0.00 | 13,450.40 | D | — | — | |
| 3 | Common | Common Stock | 2023-03-30 | F | D | 2,866 | $224.70 | 10,584.40 | D | — | — |